Related Experiment Videos
Drug-induced liver diseases (continuing education)
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Linezolid: an oxazolidinone antimicrobial agent.
Clinical therapeutics·2001
Amprenavir: a new human immunodeficiency virus type 1 protease inhibitor.
Clinical therapeutics·2000
Selective cyclooxygenase-2 inhibitors for the treatment of arthritis.
Clinical therapeutics·1999
Treatment regimens for patients with toxoplasmic encephalitis.
Clinical therapeutics·1996
Pharmacist-operated drug information centers in the United States.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1995
Clinical experience with sotalol in the treatment of cardiac arrhythmias.
Clinical therapeutics·1994
Experiences of the dying.
The Journal of practical nursing·2012
Transitioning the practical nursing student into practice: outcomes of a geriatric initiative.
The Journal of practical nursing·2012
Simulation in Kansas practical nursing programs.
The Journal of practical nursing·2012
Simulation in Kansas practical nursing programs.
The Journal of practical nursing·2012
Predicting NCLEX-PN success with the HESI Exit Exam.
The Journal of practical nursing·2011
Enhancing students' clinical experience: simple ideas that work.
The Journal of practical nursing·2010
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026